Shingles shot may shield seniors from heart attacks and dementia

NCT ID NCT07485283

Recruiting now Prevention Sponsor: Tor Biering-Sørensen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This large study in Denmark is testing whether the shingles vaccine (Shingrix) can do more than prevent shingles—it may also lower the risk of heart attacks, strokes, and dementia. About 162,000 adults aged 65 and older will either get the vaccine or no vaccine, and researchers will track their health for years. If successful, this could offer a simple way to protect older adults from some of the most common and serious age-related diseases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder herpes zoster myocardial infarction stroke disorder dementia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASE DEMENTIA

Contacts and locations

Locations

Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
NOT_YET_RECRUITING

Hellerup, 2900, Denmark
Danske Lægers Vaccinations Service
RECRUITING

Søborg, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.